These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Small cell lung cancer: new clinical recommendations and current status of biomarker assessment. Planchard D; Le Péchoux C Eur J Cancer; 2011 Sep; 47 Suppl 3():S272-83. PubMed ID: 21943984 [TBL] [Abstract][Full Text] [Related]
7. Unresected stage III non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group. Okawara G; Rusthoven J; Newman T; Findlay B; Evans W Cancer Prev Control; 1997 Aug; 1(3):249-59. PubMed ID: 9765750 [TBL] [Abstract][Full Text] [Related]
8. Emerging trends in combinations of gefitinib and cytotoxic agents: new opportunities. Tabernero J; Macarulla T Onkologie; 2005 Oct; 28(10):467-70. PubMed ID: 16285032 [No Abstract] [Full Text] [Related]
9. Treatment of small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Jett JR; Schild SE; Kesler KA; Kalemkerian GP Chest; 2013 May; 143(5 Suppl):e400S-e419S. PubMed ID: 23649448 [TBL] [Abstract][Full Text] [Related]
10. [Therapy in non-small-cell lung carcinoma (NSCLC) in local advanced stage (inoperable IIIA/IIIB)]. Baumann M; Dienemann HC; Fietkau R; Rübe C; Thomas M Onkologie; 2006 Sep; 29 Suppl 2():11-4. PubMed ID: 16974122 [No Abstract] [Full Text] [Related]
11. [Therapeutic strategy for small cell lung cancer]. Fukuoka M Nihon Geka Gakkai Zasshi; 1997 Jan; 98(1):46-52. PubMed ID: 9046518 [TBL] [Abstract][Full Text] [Related]
12. Sequential combined modality therapy for stage III non-small cell lung cancer. Vokes EE Hematol Oncol Clin North Am; 1990 Dec; 4(6):1133-42. PubMed ID: 1962780 [TBL] [Abstract][Full Text] [Related]
13. Combined modality therapy of non-small cell lung cancers. Juretic A; Sobat H; Samija M Ann Oncol; 1999; 10 Suppl 6():93-8. PubMed ID: 10676559 [TBL] [Abstract][Full Text] [Related]
14. [Recent issues in the treatment of advanced non-small-cell lung cancer]. Negoro S Gan To Kagaku Ryoho; 1998 Sep; 25(11):1671-9. PubMed ID: 9757191 [TBL] [Abstract][Full Text] [Related]
15. Patient subsets benefiting from adjuvant therapy following surgical resection of non-small cell lung cancer. Johnson BE; Rabin MS Clin Cancer Res; 2005 Jul; 11(13 Pt 2):5022s-5026s. PubMed ID: 16000607 [TBL] [Abstract][Full Text] [Related]
16. SEOM clinical guidelines for the treatment of non-small cell lung cancer (NSCLC) 2015. García-Campelo R; Bernabé R; Cobo M; Corral J; Coves J; Dómine M; Nadal E; Rodriguez-Abreu D; Viñolas N; Massuti B Clin Transl Oncol; 2015 Dec; 17(12):1020-9. PubMed ID: 26691657 [TBL] [Abstract][Full Text] [Related]
17. The treatment of non-small cell lung cancer: current perspectives and controversies, future directions. Bunn PA Semin Oncol; 1994 Jun; 21(3 Suppl 6):49-59. PubMed ID: 8052874 [TBL] [Abstract][Full Text] [Related]
18. Treatment of small cell lung cancer. Morabito A; Carillio G; Daniele G; Piccirillo MC; Montanino A; Costanzo R; Sandomenico C; Giordano P; Normanno N; Perrone F; Rocco G; Di Maio M Crit Rev Oncol Hematol; 2014 Sep; 91(3):257-70. PubMed ID: 24767978 [TBL] [Abstract][Full Text] [Related]
19. Survival of patients with advanced non-small-cell lung cancer at Ubon Ratchathani Cancer Center, Thailand. Srisam-Ang K; Podhipak A; Narksawat K; Supaattagorn P; Tipayamongkholgul M Southeast Asian J Trop Med Public Health; 2005 Jul; 36(4):994-1006. PubMed ID: 16295558 [TBL] [Abstract][Full Text] [Related]
20. [Evidence-based practice guideline for unresectable advanced lung cancer in 2003]. Fukuoka M; Kurata T; Yamamoto N Nihon Geka Gakkai Zasshi; 2004 Jul; 105(7):412-6. PubMed ID: 15303441 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]